IMproved PREdiction of Severe Sepsis in the Emergency Department

Completed

• Conditions: Severe Sepsis; Septic Shock; Systemic Inflammatory Response Syndrome (SIRS); Sepsis

• Registration Number: NCT01392508
• Lead Sponsor: Axis Shield Diagnostics Ltd

Brief Summary

The purposes of this study is to determine whether Heparin Binding Protein (HBP) can be used as a marker of severe sepsis (including septic shock) in patients presenting to the emergency department with suspected infection.

Detailed Description

Not available

Study Timeline

• Study Start: 2011-03
• Study First Submitted: 2011-07-11
• Study First Submitted QC: 2011-07-11
• Study First Posted: 2011-07-12
• Primary Completion: 2015-09
• Study Completion: 2015-09
• Status Verified: 2017-04
• Last Update Submitted: 2017-04-13
• Last Update Posted: 2017-04-14

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 759

Inclusion Criteria

• Greater than or equal to 18 years
• Suspected Infection
• one or more SIRS criteria

Exclusion Criteria

Not provided

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Trial Locations

Locations (5)

Cooper University Hospital; 🇺🇸 Camden, New Jersey, United States

Universitetssjukhuset i Linkoping; 🇸🇪 Linkoping, Sweden

Skanes Universitetssjukhus i Lund; 🇸🇪 Lund, Sweden

Skanes Universitetssjukhuset i Malmo; 🇸🇪 Malmo, Sweden

Universitetssjukhuset i Orebro; 🇸🇪 Orebro, Sweden